Literature DB >> 24867114

Lung cancer screening guidelines. The nurse's role in patient education and advocacy.

Rebecca H Lehto1.   

Abstract

Although the third leading cancer in incidence following breast and prostate, lung cancer is the principal cause of cancer death in the United States. The majority of lung cancer cases are detected at an advanced stage when surgical resection is no longer an option. Recent research has concluded that lung cancer screening with low-dose computed tomography for specific high-risk groups may reduce lung cancer mortality. Public awareness and the need for current information are growing regarding the state of the science relative to lung cancer screening for individuals at high risk for lung cancer. This article provides a historical perspective on the topic of lung cancer screening. The risks and benefits of screening are discussed, and current clinical practice guidelines are reviewed. Oncology nurses will need to be cognizant of the risks, benefits, and current guidelines related to lung cancer screening as they support patients and their families making informed decisions about personal health care.

Entities:  

Keywords:  lung cancer; patient/public education; prevention and detection

Mesh:

Year:  2014        PMID: 24867114     DOI: 10.1188/14.CJON.338-342

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  3 in total

1.  The effect of targeted nursing on the quality of sleep and life in lung cancer patients undergoing chemotherapy.

Authors:  Hongmei Wang; Yuan Liang; Duo Lu; Yuwei Zhao
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer.

Authors:  Johnathan D Ebben; Ronald A Lubet; Ekram Gad; Mary L Disis; Ming You
Journal:  Mol Carcinog       Date:  2015-09-07       Impact factor: 4.784

Review 3.  Spiritual Assessment in a Patient With Lung Cancer.

Authors:  Tami Borneman
Journal:  J Adv Pract Oncol       Date:  2014 Nov-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.